跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OZANEX - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OZANEX
Authorized
STANDARD
OZANEX
Ferrer Internacional S.A.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
76d2de917d16e07d
Company
Ferrer Internacional S.A.
Type
Standard
Approval Details
Approval Id
76d2de917d16e07d
Drug Approval Canada Name
OZANEX
Product Name
OZANEX
Status
Dormant
Status Date
2024-07-11
Original Market Date
2018-01-04
Din
02463504
Drug Class
Human
Dosage Form
Cream
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:04.04
Atc Original
D06AX14 OZENOXACIN
Atc Name
d 06 ax 14
Aig Number
0159010001
Company Name
Ferrer Internacional S.A.
Company Address
Gran Via Carlos Iii,94, Barcelona, Catalonia, Spain, 08028
Company Detail Path
/organization/ferrer-internacional-s-a
Company Information
Pharmaceutical Company Name
Ferrer Internacional S.A.
Country Name
Chile
Province Name
santiago,country_cl
City Name
santiago,santiago,country_cl
Address
Av Quilin 5273
Active Ingredients
OZENOXACIN
1 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
76d2de917d16e07d
Type
Standard
Back to Health Canada Approvals